- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Novo Nordisk was ruled in breach for failures to disclose, late disclosure, and inaccurate/misplaced reporting of transfers of value to HCOs and…
Complaint alleged a Rosemont LinkedIn post and website content promoted a specific POM to the public and lacked certification. Panel found the…
AbbVie failed to recertify an AbbVie Pro “Oncology Focus Area” landing page within the required two-year interval. PMCPA found a breach of…
Complaint alleged pre-licence promotion via a LinkedIn post linking to a GSK press release about Aiolos Bio acquisition and AIO-001 in asthma.…
GSK-sponsored COPD decision support tool lacked a prominent sponsorship declaration at the outset of the homepage after sponsorship ended. PMCPA ruled a…
Two Alliance representatives raised litigation/medico-legal consequences during a promotional meeting about Eliquis amid cost-driven switching to Lixiana. The Panel found scaremongering and…
A pharmacist challenged a Lyrinel XL ad’s “Gets our vote” imagery. The Panel found the illustration exaggerated satisfaction by ignoring discontinuations and…
Teva challenged two Trinity-Chiesi clinical support service pharmacist forms implying increased use of Clenil Modulite. The Panel found the complaint was too…
AstraZeneca challenged Trinity-Chiesi’s Fostair cost comparison chart as incomplete and misleading versus Symbicort and Seretide. The Panel found the chart acceptable in…
Complaint about Lantus promotional leavepieces and a mailer. Issues included “24-hour efficacy” wording and a hypoglycaemia comparison based on pooled observational data.…
A GP complained about an unsolicited promotional email for MacroBid sent to his NHS email via an agency. The Panel and Appeal…
The MHRA complained that a Zoladex journal advertisement referenced the MHRA. The Panel ruled this breached Clause 9.5 because such references are…
Anonymous complaint alleged Merck Serono encouraged off-licence promotion of Pergoveris via internal emails targeting Menopur IVF/ICSI cycles. Panel found emails unclear on…
Anonymous complaint questioned GSK’s POINTS COPD audit service (consent complexity, data access, inducement). PMCPA found clear separation of promotional/non-promotional roles and no…
Abbott admitted a rep’s Synagis email to HCPs was promotional but uncertified, lacked prescribing info, included an off-licence JCVI recommendation, and was…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.